Assets 更改
AbbVie USD 148.87B 12.65B 2024-03
Abbott USD 72.47B 887M 2024-03
ALKERMES USD 2.12B 12.33M 2024-03
Amgen USD 92.98B 4.17B 2024-03
AstraZeneca USD 102.29B 1.17B 2024-03
Biogen USD 26.57B 277.2M 2024-03
BioMarin Pharmaceutical USD 6.87B 31.07M 2024-03
Bristol-Myers Squibb USD 99.03B 7.77B 2024-03
Eisai JPY 1.31T 22.76B 2023-12
Eli Lilly USD 63.94B 6.03B 2024-03
Gilead Sciences USD 56.29B 5.83B 2024-03
GlaxoSmithKline GBP 58.51B 494M 2024-03
J&J USD 171.97B 5.9B 2024-03
Medtronic USD 90.84B 749M 2024-01
Merck USD 105.85B 878M 2024-03
Neurocrine Biosciences USD 3.47B 624.2M 2024-03
Novartis USD 94.33B 5.61B 2024-03
Pacira USD 1.58B 8.93M 2024-03
Perrigo USD 10.64B 168.8M 2024-03
Pfizer USD 221.1B 6.07B 2024-03
Regeneron Pharmaceuticals USD 34.37B 1.29B 2024-03
Roche Holding CHF 90.47B 6.1B 2023-12
UCB EUR 15.54B 157M 2023-12
Ultragenyx Pharmaceutical USD 1.31B 183.93M 2024-03
United Therapeutics USD 6.5B 671.8M 2024-03
Vertex Pharmaceuticals USD 23.92B 2.19B 2024-03
Zoetis USD 14.35B 62M 2024-03



AbbVie 资产 - 当前值,历史数据,预测,统计,图表和经济日历 - Jun 2024.